| pubmed-article:17123441 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C0205102 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C0018270 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C1704259 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C1705987 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C0281398 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:17123441 | lifeskim:mentions | umls-concept:C1516044 | lld:lifeskim |
| pubmed-article:17123441 | pubmed:dateCreated | 2006-11-29 | lld:pubmed |
| pubmed-article:17123441 | pubmed:abstractText | Standard chemotherapy protocols in NSCLC are of limited clinical benefit. Histone deacetylase (HDAC) inhibitors represent a new strategy in human cancer therapy. In this study the combination of the HDAC inhibitor phenylbutyrate (PB) and the nucleoside analogue gemcitabine (GEM) was evaluated and the mechanisms underlying increased cell death were analyzed. | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17123441 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17123441 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:17123441 | pubmed:issn | 1477-3163 | lld:pubmed |
| pubmed-article:17123441 | pubmed:author | pubmed-author:KalthoffHolge... | lld:pubmed |
| pubmed-article:17123441 | pubmed:author | pubmed-author:KurdowRolandR | lld:pubmed |
| pubmed-article:17123441 | pubmed:author | pubmed-author:SchniewindBod... | lld:pubmed |
| pubmed-article:17123441 | pubmed:author | pubmed-author:DohrmannPeter... | lld:pubmed |
| pubmed-article:17123441 | pubmed:author | pubmed-author:AmmerpohlOleO | lld:pubmed |
| pubmed-article:17123441 | pubmed:author | pubmed-author:TrauzoldAnnaA | lld:pubmed |
| pubmed-article:17123441 | pubmed:author | pubmed-author:HeintzKirsten... | lld:pubmed |
| pubmed-article:17123441 | pubmed:author | pubmed-author:EmmeDorisD | lld:pubmed |
| pubmed-article:17123441 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17123441 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:17123441 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17123441 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17123441 | pubmed:pagination | 25 | lld:pubmed |
| pubmed-article:17123441 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:17123441 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17123441 | pubmed:articleTitle | Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways. | lld:pubmed |
| pubmed-article:17123441 | pubmed:affiliation | Hospital for General and Thoracic Surgery, Schleswig-Holstein University Hospitals, Campus Kiel, Arnold-Heller-Str 7, Kiel, Germany. schniewind@surgery.uni-kiel.de | lld:pubmed |
| pubmed-article:17123441 | pubmed:publicationType | Journal Article | lld:pubmed |
